Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1005193-64-5
2. N-ethyl Fluprostenol Carboxamide
3. (5z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(1e,3r)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-n-ethyl-5-heptenamide
4. (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e,3r)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]-n-ethylhept-5-enamide
5. Trifluoromethyldechloro
6. A850975
| Molecular Weight | 485.5 g/mol |
|---|---|
| Molecular Formula | C25H34F3NO5 |
| XLogP3 | 3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 12 |
| Exact Mass | 485.23890767 g/mol |
| Monoisotopic Mass | 485.23890767 g/mol |
| Topological Polar Surface Area | 99 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 669 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
A Trifluoromethyl Dechloro Ethylcloprostenolamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trifluoromethyl Dechloro Ethylcloprostenolamide, including repackagers and relabelers. The FDA regulates Trifluoromethyl Dechloro Ethylcloprostenolamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trifluoromethyl Dechloro Ethylcloprostenolamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trifluoromethyl Dechloro Ethylcloprostenolamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trifluoromethyl Dechloro Ethylcloprostenolamide supplier is an individual or a company that provides Trifluoromethyl Dechloro Ethylcloprostenolamide active pharmaceutical ingredient (API) or Trifluoromethyl Dechloro Ethylcloprostenolamide finished formulations upon request. The Trifluoromethyl Dechloro Ethylcloprostenolamide suppliers may include Trifluoromethyl Dechloro Ethylcloprostenolamide API manufacturers, exporters, distributors and traders.
click here to find a list of Trifluoromethyl Dechloro Ethylcloprostenolamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Trifluoromethyl Dechloro Ethylcloprostenolamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trifluoromethyl Dechloro Ethylcloprostenolamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trifluoromethyl Dechloro Ethylcloprostenolamide GMP manufacturer or Trifluoromethyl Dechloro Ethylcloprostenolamide GMP API supplier for your needs.
A Trifluoromethyl Dechloro Ethylcloprostenolamide CoA (Certificate of Analysis) is a formal document that attests to Trifluoromethyl Dechloro Ethylcloprostenolamide's compliance with Trifluoromethyl Dechloro Ethylcloprostenolamide specifications and serves as a tool for batch-level quality control.
Trifluoromethyl Dechloro Ethylcloprostenolamide CoA mostly includes findings from lab analyses of a specific batch. For each Trifluoromethyl Dechloro Ethylcloprostenolamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trifluoromethyl Dechloro Ethylcloprostenolamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Trifluoromethyl Dechloro Ethylcloprostenolamide EP), Trifluoromethyl Dechloro Ethylcloprostenolamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trifluoromethyl Dechloro Ethylcloprostenolamide USP).
LOOKING FOR A SUPPLIER?
